Composition of Certain Financial Statement Captions (Tables)

12 Months Ended

Dec. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Composition of Certain Financial Statement Captions

	For the years ended December 31,
(In thousands)	2021		2020
Accounts receivable, net
Accounts receivable	$	261,476	$	288,369
Less: allowance for doubtful accounts	(1,839)		(2,055)
	$	259,637	$	286,314
Inventories, net
Consumable supplies	$	39,447	$	86,779
Finished products	44,107		36,831
Work in-process	1,615		5,268
Raw materials	6,112		5,784
Less: inventory reserve	(4,779)		(2,321)
	$	86,502	$	132,341
Other current assets and prepaid expenses
Prepaid supplies	$	10,641	$	7,259
Prepaid insurance	4,383		3,803
Taxes recoverable	5,598		13,440
Other receivables	353		2,502
Other	6,195		5,309
	$	27,170	$	32,313
Property, plant and equipment, net:
Machinery, medical and other equipment	$	127,633	$	193,152
Leasehold improvements	27,478		40,742
Furniture and fixtures	11,638		13,547
Automobiles and aircraft	12,602		10,537
Software	14,507		14,726
Building	10,661		21,848
Land	2,421		2,602
Construction in process	6,113		8,169
Less: accumulated depreciation	(133,326)		(164,769)
	$	79,727	$	140,554
Intangible assets, net:
Customer relationships	$	314,823	$	448,751
Technologies	246,101		296,623
Trade names	49,770		49,820
Covenants not to compete	12,920		16,334
Licenses	5,766		5,766
Product registrations	6,995		8,025
Other	6,128		6,513
Less: accumulated amortization	(320,820)		(356,830)
	$	321,683	$	475,002

	For the years ended December 31,
(In thousands)	2021		2020
Accrued expenses:
Inventory received but not invoiced	$	40,446	$	72,160
Employee benefits	45,939		43,300
Commitments and contingencies	27,819		15,454
Clinical trials	4,867		7,112
Finance leases short-term	2,257		2,453
Professional fees	2,121		4,985
Contingent consideration	487		1,188
Contract liabilities	258		15,783
Other	69,299		78,434
	$	193,493	$	240,869
Other long-term liabilities:
Finance leases long-term	$	2,924	$	2,805
Contingent consideration	2,350		4,507
Mortgages and other debts payable	2,224		3,837
Contract liabilities	208		595
Other	7,356		25,328
	$	15,062	$	37,072

Summary of Valuation Allowance

The following table reflects the changes in the allowance for doubtful accounts, provision for inventory reserve and tax valuation allowance accounts:

(In thousands)	Beginning balance		Charged to expense	Written-off	Charged to other	Ending balance
2021
Allowance for doubtful accounts	$	(2,055)	(369)	585	—	$	(1,839)
Inventory reserve	$	(2,321)	(6,461)	4,003	—	$	(4,779)
Tax valuation allowance	$	(303,326)	34,496	—	8,433	$	(260,397)
2020
Allowance for doubtful accounts	$	(1,934)	(232)	111	—	$	(2,055)
Inventory reserve	$	(2,537)	(4,387)	4,603	—	$	(2,321)
Tax valuation allowance	$	(193,256)	(110,070)	—	—	$	(303,326)

Changes in Goodwill

The following table summarizes the changes in Goodwill by reporting unit during the years ended December 31, 2021 and 2020.

	2021										2020
(In thousands)	Gross goodwill at January 1		Cumulative impairment at January 1		Goodwill impairment		Foreign exchange and other		Balance at December 31st		Gross goodwill at January 1		Cumulative impairment at January 1		Goodwill impairment		Foreign exchange and other		Balance at December 31st
Pharmaceuticals
CURNA	$	4,827	$	(4,827)	$	—	$	—	$	—	$	4,827	$	(4,827)	$	—	$	—	$	—
Rayaldee	93,418		—		—		(6,865)		86,554		85,605		—		—		7,813		93,418
FineTech	11,698		(11,698)		—		—		—		11,698		(11,698)		—		—		—
OPKO Biologics	139,784		—		—		—		139,784		139,784		—		—		—		139,784
OPKO Chile	4,505		—		—		(745)		3,760		4,348		—		—		157		4,505
OPKO Health Europe	8,086		—		—		(608)		7,478		7,394		—		—		692		8,086
OPKO Mexico	100		(100)		—		—		—		100		(100)		—		—		—
Transition Therapeutics	3,421		(3,421)		—		—		—		3,421		(3,421)		—		—		—
Diagnostics
BioReference	434,809		—		—		(151,784)		283,025		434,809		—		—		—		434,809
OPKO Diagnostics	17,977		(17,977)		—		—		—		17,977		(17,977)		—		—		—
	$	718,625	$	(38,023)	$	—	$	(160,002)	$	520,601	$	709,963	$	(38,023)	$	—	$	8,662	$	680,602